학술논문
Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial
Document Type
Article
Author
Source
In The Lancet 14-20 August 2021 398(10300):583-598
Subject
Language
ISSN
0140-6736